Erythropoietin, a protein, is a potent ischemia-induced angiogenic factor that acts independently of VEGF during retinal angiogenesis in proliferative diabetic retinopathy. Turmerin, a protein of Curcuma longa L. Inspite of many other medicinal properties possesses antidiabetic properties too. The molecular interactions of erythropoietin and turmerin were studied for exploring the protein-protein interaction against diabetic retinopathy.
INTRODUCTION
Diabetic retinopathy is caused by complications of diabetes mellitus, which can eventually lead to blindness. 1 Erythropoietin, a protein, possesses angiogenic activity. This protein is a potent ischemia-induced angiogenic factor that acts independently of VEGF during retinal angiogenesis in proliferative diabetic retinopathy. [2] [3] [4] Turmeric (Curcuma longa L) is a medicinal plant extensively used in Ayurveda,
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Unani and Siddha medicine as home remedy for various diseases. C longa L, botanically related to ginger (Zingiberaceae family), is a perennial plant having a short stem with large oblong leaves and bears ovate, pyriform or oblong rhizomes, which are often branched and brownishyellow in color. [5] [6] [7] [8] It has been used in traditional medicine as a household remedy for various diseases. [9] [10] [11] For the last few decades, extensive work has been done to establish the biological activities and pharmacological actions of turmeric and its extracts. Curcumin (diferuloylmethane), the main yellow bioactive component of turmeric has been shown to have a wide spectrum of biological actions. These include its anti-inflammatory, antioxidant, anticarcinogenic, antimutagenic, anticoagulant, antifertility, antibacterial, antifungal, antiprotozoal, antiviral, antifibrotic, antivenom, antiulcer, hypertensive and hypocholesteremic activities.
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Besides curcumin another important component of turmeric is turmerin. Turmerin is a 34 kDa protein isoloated from Curcuma longa is also reported to show good medicinal values including antioxidant properties. 13 Inspite of many other medicinal properties turmerin also contains antidiabetic properties. 14 The molecular interactions of erythropoietin and turmerin were studied for exploring the protein-protein interaction against diabetic retinopathy.
METHODS
The protein sequence of turmerin was obtained from GenBank (Acc. No. P85278). 15, 16 Modeling templates were searched by using BLAST. 17, 18 In order to analyze modeled complex of protein-protein interaction, sequence identity of 40 to 50% between target and template may be required. Multiple sequence alignment was performed by using ClustalW. The atomic coordinates was retrieved from Protein Data Bank, (PDB ID: 1AVW, 1AVX and 1BA7). Molecular structures of turmerin were modeled by using restraint-based modeling implemented in the program Modeller 9.9. 19 Several models were generated and were then energy minimized using the molecular dynamics and simulation procedure in program Modeller 9.9. The quality and stereochemistry of the models were evaluated using the program Procheck. 20 The final model was selected based on stereochemical quality. The main-chain conformations for 98.80% amino acid residues were within the favored or allowed regions of the Ramachandran plot and the overall G-factor was indicating that molecular geometry of the model is of good quality. The selected model was further refined by energy minimization by the NAMD 2.7 program by 2,000 steps of conjugate gradient minimization. 21 Structural models were visualized by Chimera. 22 Turmerin model was docked to human erythropoietin using Hex 4.5.
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The atomic coordinates of human erythropoietin was retrieved from PDB (PDB ID: 1CN4). 24 Automated energy minimization was applied to each docking solution. The Chimera program was exploited to identify hydrogen bonds using default parameters and geometric criteria. Mark Gerstein's calc-surface program, which is implemented in the program Chimera, was used to calculate the solvent accessibility at the interface of turmerin and human erythropoietin before and after docking.
RESULTS

Template Identification and Model Quality
Crystal structure of human erythropoietin has already been determined and is available in PDB. Based on sequence similarity analysis, turmerin showed 55% amino acid sequence identity with templates ( Fig. 1) . It was one of top ranks with high degree of sequence identities between turmerin and other templates with known structures. Practically, at this level of sequence identity, it was adequate to use crystallographic structures of templates, in order to obtain high quality alignment for structure prediction by homology modeling. The crystal structures of 1AVW, 1AVX and 1BA7 was specifically selected on the basis of Blast result and was utilized as a template for turmerin structure modeling. Structural models for turmerin were built by Modeller 9.9 program based on atomic coordinates of templates and were then energy minimized. The model with the lowest objective function which was considered as the best one was selected and subjected to quality evaluation. The Procheck Ramachandran plot analysis showed that the main-chain conformations for 98.80% of amino acid residues were within the most favored or allowed regions (Fig. 2 ). The structural model of turmerin is shown in Figure 3A . The G-factors, indicate the quality of covalent and bond-angle distance. The overall main-chain and sidechain parameters, as evaluated by Procheck, were favorable. The comparable Ramachandran plot characteristic and Gfactors confirmed the quality of predicted model. The overall conformation of turmerin model was similar to templates. Turmerin active sites were predicted (Fig. 3B) .
Interaction of Turmerin and Human Erythropoietin
Based on rigid-body docking using Hex 4.5, both proteins were analyzed for shape complementary, hydrophobic effects resulting from a decrease in the solvent accessible surface and electrostatic interactions. The key amino acid residues within the docking complex model involved in the interaction between turmerin (t) and human erythropoietin (e) are tVal10, tLeu11, tSer28, tThr54, tGly66, tPro 77 and ePro7, eCys39, eVal98, eLeu129,eThr146, eMet198, eSer211. These residues were determined based on active site which lies on protein surface and intermolecular hydrogen bond lengths of amino acid residues interacted between human erythropoietin and turmerin through deep view tool (Fig. 4) . 25 The docking result indicated that the complex could be stabilized by hydrogen bonding (Fig. 5) . Hydrophobic effect is shown on the complex (Figs 6A  and B) .
DISCUSSION
The rationale in building a turmerin model and performing a binding study with human erythropoietin is to gain details of interaction between the two proteins. Turmerin modeling was conducted using homology modeling. Comparison of the obtained model with experimentally derived crystal structures of templates revealed that they were all basically similar. The docking studies revealed the important residues involving in the interaction of turmerin with human erythropoietin. Analyses of the interaction model between human erythropoietin and turmerin, based on distances of hydrogen bonds, changes of solvent accessible surface, electrostatic potentials, showed that this binding complex is reliable. These protein-protein interactional studies may be very significant in contributing the dimensions of new herbal medicinal avenues. Finding of these current studies may give new directions for developing as well as in contributing the new establishment of treatments by using herbal approaches. Turmerin as a herbal protein was found good inhibitor against erythropoietin, a very important targeted protein in diabetic retinopathy. As pure form of turmerin is commercially available hence, it can be advice to use it as a better alternative herbal therapy after proper dose monitoring by in vitro studies. Further verifications and validations through in vivo studies may give more authentic outcome to this study. The interaction between human erythropoietin and turmerin proposed in this study is useful for understanding the possible mechanism used by human erythropoietin to 
